tiprankstipranks
pc:artbi

ARTBIO

Kendall Sq c/o Alexandria LaunchLabs B200, Suite 001 Cambridge, Massachusetts 02139, US
https://www.artbio.com/
ARTBIO is a biotechnology company specializing in the development of alpha radioligand therapies. The company is focused on advancing its lead asset, AB001, through clinical development and progressing additional programs toward investigational new drug (IND) readiness. ARTBIO also emphasizes expanding its manufacturing and supply chain infrastructure, utilizing its proprietary generator technology to enhance its operations.

Leadership & Board

Current Number of Employees73
Current LinkedIn Followers12,584

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$132M
Total Amount Raised$132M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$132M
Latest Funding Amount$132M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Employee Trend

ARTBIO had 73 employees as of April 27, 2026. The number of employees decreased by 1 (1.35%) week-over-week.
73Latest Employee Count
1(-1.35%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

ARTBIO had 12,584 followers as of April 27, 2026. The number of followers increased by 56 (0.45%) week-over-week.
12,584Latest Followers Count
56(0.45%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 29, 2025
Series B
$132.00M

Investors

Related News and Analysis